-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------
C.E.O. Interviews
03.12.2007
Erlangen, 3rd December 2007. Dr. Claus Müller has asked the supervisory board of november AG to release him from all duties related to his present office as CEO of the company for health reasons with immediate effect. The supervisory board has granted the request. Dr. Claus Müller will step down as managing director of IBL Hamburg, identif GmbH and directif GmbH as well effective from the same day.
end of announcement euro adhoc 03.12.2007 10:46:11 --------------------------------------------------------------------------------
ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.de
Further inquiry note:
Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de
Branche: Biotechnology ISIN: DE000A0S9N72 WKN: A0S9N7 Index: CDAX, Technologie All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hannover / free trade Börse München / free trade
